Thermo Fisher Scientific Noncontrolling interests in subsidiaries remained flat by 0.0% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 121.2%, from -$33.00M to $7.00M. Over 5 years (FY 2020 to FY 2025), Noncontrolling interests in subsidiaries shows a downward trend with a -6.9% CAGR.
Changes reflect the acquisition or divestiture of minority stakes in subsidiaries or the relative profitability of those specific entities.
This represents the portion of equity in a subsidiary that is not attributable, directly or indirectly, to the parent co...
Common in companies with complex organizational structures and joint ventures.
other_minority_interest| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.00M | $62.00M | $61.00M | $59.00M | $54.00M | $53.00M | $50.00M | $18.00M | -$11.00M | -$12.00M | -$12.00M | -$20.00M | -$33.00M | -$33.00M | -$35.00M | $7.00M | $7.00M | $7.00M |
| QoQ Change | — | +0.0% | -1.6% | -3.3% | -8.5% | -1.9% | -5.7% | -64.0% | -161.1% | -9.1% | +0.0% | -66.7% | -65.0% | +0.0% | -6.1% | +120.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -12.9% | -14.5% | -18.0% | -69.5% | -120.4% | -122.6% | -124.0% | -211.1% | -200.0% | -175.0% | -191.7% | +135.0% | +121.2% | +121.2% |